Skewing the aim of targeted cancer therapies
Tuesday, August 15, 2017 - 10:32
in Health & Medicine
The aim of targeted gene-based cancer therapies could often be skewed from the start. A widespread concept about how cells produce proteins proved incorrect 62 percent of the time in a new study in ovarian cancer cells on the relationship between RNA and protein levels.